SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

Morgan Stanley Maintains Overweight on MyoKardia, Raises Price Target to $87

Morgan Stanley maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $83 to $87.

Benzinga · 05/07/2020 12:53

Morgan Stanley maintains MyoKardia (NASDAQ:MYOK) with a Overweight and raises the price target from $83 to $87.